On February 12, 2004, The Endocrine Society will host an audioconference to examine the issues regarding the newly defined thyroid stimulating hormone (TSH) range, the new approach for detecting and managing subclinical thyroid disease and the use of thyroid hormone replacement therapy.
The audioconference, which will be led by several recognized thyroid experts, will feature discussions on research from the October 2003 issue of the Journal of Clinical Endocrinology & Metabolism and the January 14th issue of Journal of the American Medical Association.
An opportunity for questions and comments will be provided at the end of the faculty presentations. Participation in the audioconference is free and open to the press. For additional information about the audioconference, please visit http://www.endo-society.org/education/cme_audio.cfm#thyroid
What:
Audioconference: Current Issues in Thyroid Disease Management Implications from JAMA and JCEM Reports
When:
Thursday, February 12, 2004
3:00 4:30 pm (EST)
Speakers:
Contact:
Marisa Lavine
The Endocrine Society
Phone: 301-941-0255
Email: mlavine@endo-society.org
Reporters who would like to register for the audioconference should send their name, email a
'"/>